While the recent spate of positive regulatory updates boosts Bristol Myers, we will advise a wait-and-watch strategy.
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are […]